Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.980
-0.110 (-3.56%)
At close: Oct 30, 2025, 4:00 PM EDT
2.980
0.00 (0.01%)
After-hours: Oct 30, 2025, 7:57 PM EDT

Chemomab Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$26.50
Upside
+789.26%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
BuyMaintains$10$25+738.93%Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
BuyMaintains$44$40+1,242.28%May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong BuyMaintains$16$28+839.60%Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
BuyReiterates$52$44+1,376.51%Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong BuyInitiates$16+436.91%May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
BuyUpgrades$24+705.37%May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
HoldMaintainsn/an/aMar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+839.60%Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+839.60%Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
BuyMaintains$48$28+839.60%Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
BuyMaintains$120$80+2,584.56%Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong BuyInitiates$120+3,926.85%Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
BuyInitiates$180+5,940.27%May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
BuyInitiates$168+5,537.58%May 7, 2021